Medicx Fund (MXF) Earns Buy Rating from Liberum Capital

Liberum Capital reissued their buy rating on shares of Medicx Fund (LON:MXF) in a research note released on Wednesday.

MXF opened at GBX 0.76 ($0.01) on Wednesday. Medicx Fund has a 1-year low of GBX 76.75 ($1.00) and a 1-year high of GBX 92.50 ($1.21).

The company also recently disclosed a dividend, which will be paid on Monday, December 31st. Shareholders of record on Thursday, November 15th will be given a dividend of GBX 1.51 ($0.02) per share. This represents a yield of 1.89%. The ex-dividend date of this dividend is Thursday, November 15th.

Medicx Fund Company Profile

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.

Recommended Story: S&P 500 Index

Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply